*Exercise Support: Propionyl-l-carnitine, acetyl-l-carnitine and l-carnitine fumarate

• Patented synergistic combination for facilitating the adaptation of skeletal muscle in individuals undergoing strenuous exercise*
• Patented synergistic combination for lessening muscle fatigue in individuals, regardless of degree of physical activity*
• Fuels the Krebs cycle at the acetyl CoA level (acetyl-l-carnitine) and the succinyl-CoA level (propionyl-l-carnitine)*
• Provides direct support for the transport and oxidation of fatty acids into the mitochondria (l-carnitine fumarate), providing an important
  source of muscular energy*

Cardiovascular Support: Propionyl-l-carnitine and CoQ10 

• Patented synergistic combination for vascular and lipid support properties*
• Provides specific vascular support by promoting healthy peripheral circulation in addition to fatty acid oxidation and ATP synthesis*
• Provides a greater affinity for cardiac and skeletal muscles with propionyl-l-carnitine while enhancing mitochondrial function, energy production, and vascular health with the metabolic activities of CoQ10*

Enhanced Support: d-Ribose

• Backed by over 150 studies indicating the potential to increase adenosine triphosphate (ATP) levels, providing energy for healthy skeletal muscle*
• Provides support for healthy diastolic cardiac function*

 

 

three vegetable capsules contain:
d-ribose	1,000 mg.
l-carnitine (free-form)	250 mg.
(from l-carnitine fumarate)
GlycoCarn® GPLC	150 mg.
(glycine propionyl-l-carnitine HCl)
acetyl-l-carnitine	125 mg.
(from acetyl-l-carnitine HCl)
coenzyme Q10	50 mg.
ascorbyl palmitate	60 mg.
(fat-soluble vitamin C)
other ingredients: hypo-allergenic plant fiber, silica

3–6 capsules per day, in divided doses, with meals.

 

GlycoCarn® is a registered trademark of Sigma-Tau HealthScience and is manufactured under U.S. Patent 6,703,042 and European patent 1,202,956. The combination of GlycoCarn® GPLC and CoQ10 is patented by Sigma-Tau Industries under U.S. Patent 6,814,972. The combination of GlycoCarn® GPLC, l-carnitine and acetyl-l-carnitine is patented under U.S. Patent 6,245, 378. 
Use of d-ribose by Pure Encapsulations is authorized by Bioenergy, Inc. under U.S. Patents 4,605,644; 4,719, 201.

 

 

 

 

 

 

 

FDA Required Medical Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information on this web site is for general informational purposes only. It is not a substitute for a medical evaluation. If you feel that medical interventions are necessary, please check with your physician MD or ND and www.fda.gov Dietary Supplements.